1. Atkinson M, Eisenbarth G: Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001, 358:221–229.

2. Eisenbarth GS:Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 1986, 314:1360–1368.

3. Karvonen M,Tuomilehto J, Libman I, LaPorte R:WHO Diamond Project Group: a review of the recent epidemiological data on incidence of type I (insulin-dependent) diabetes mellitus worldwide. Diabetologia 36:883–892.

4. LaPorte RE, Matsushima M, Chang Y-F: Prevalence and incidence of insulin dependent diabetes. In Diabetes in America. Edited by Harris M. Bethesda, MD: NIH Publications; 1995:37–46.

5. Hawkins HW: Could the aetiology of IDDM be multifactorial? Diabetologia 1997, 40:1235–1240.

6. She JX: Susceptibility to type I diabetes: HLA-DQ and DR revisited. Immunol Today 1996, 17:323–329.

7. Field LL: Genetic linkage and association studies of Type 1 diabetes: challenges and rewards. Diabetologia 2002, 45:21–35.

8. Foulis AK: In Textbook of Diabetes.Vol. 1. Edited by Pickup J,Williams G. Oxford, England: Blackwell Scientific; 1991.

9. Krischer JP, Schatz D, Riley WJ, et al.: Insulin and islet cell autoantibodies as time-dependent covariates in the development of insulin-dependent diabetes. J Clin Endocrinol Metab 1993, 77:743–749.

10. Mathis D,Vence L, Benoist C: Beta-cell death during progression to diabetes. Nature 2001, 414:729798.

11. Kolb H, Kolb-Bachofen V: Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? Immunol Today 1998, 19:556-561.